Abstract
The antiarrhythmic actions of MJ 1999 (4-(2-iso-propylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride) and iproveratril were compared with the reference drugs quinidine and pronethalol against four types of experimentally-induced cardiac arrhythmias in dogs. Quinidine was consistently the most effective of the four compounds tested, suppressing 89% of all arrhythmias treated. Iproveratril in very small doses was effective against all four types of experimentally-induced arrhythmias, especially against the ventricular arrhythmias induced by hydrocarbonepinephrine and ouabain. The range of its potency on a micrograms per kilogram basis was from approximately twice that of quinidine and pronethalol against aconitine-induced atrial arrhythmias to about 30 times that of quinidine and pronethalol vs. coronary artery ligation-induced ventricular arrhythmias. The beta-adrenergic receptor blocking compound MJ 1999 was not effective in suppressing ouabain-induced tachycardia, but it was effective in suppressing aconitine- and coronary artery ligation-induced arrhythmias. MJ 1999 was highly effective in blocking hydrocarbon-epinephrine-induced arrhythmias at a dose that was in the range of its beta-adrenergic receptor blocking dose. MJ 1999 had an antiarrhythmic potency approximately twice that of pronethalol against all arrhythmias except ouabain-induced tachycardia.
Footnotes
- Received September 6, 1966.
- © 1967 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|